Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Shorthound, I didn't say that IVOB has 150 clinics. I just posted the news of Kevin Doody has joined the board and the article of his joining doesn't say there are 150 clinics that the Invo-cell is available in all of them so why the tirade and delirium about that - GLTU
HCIT
The delirium is running like wildflowers here.
Where do you all get that the WINFertility announcement meant they have 150 addtl clinics?
The only tie to WINFertility is that PREG, an existing INVOcell clinic has partnered with them. This does not mean that all the clinics in the WINFertility portfolio are offering INVOcell.
http://www.winfertility.com/?s=invocell
http://www.winfertility.com/simply-ivf-method-invocell-solution-infertility-patients/
http://www.winfertility.com/pregonline/
Good lord, ...."he's in the field" ???
Do you even know what his role has been in all of this?
I think it has been number one priority but it is/was a very tall order! Considering it was not being down directly by anybody on the board, they all had other things t tend to like making money, pushing the product, training doctors etc.. I am perfectly satisfied with how this is all happening at this point. And after seeing the latest filing, I can see why it took so long.
Thanks stockgenius for agreeing. FIN's should definitely be a strong priority and shareholders are supporting the company and we should get what is expected.
I still love what they're doing with the Invocell procedure and now the have a nationwide fertility organization signed up.
Love it - GLTU
HCIT
Completely agree, getting financials done has been a disaster and should have been #1 priority
New clinics being added like hotcakes now!
http://www.winfertility.com/simply-ivf-method-invocell-solution-
infertility-patients/
Whats amazing about this announcement is that WinFertility has 150 locations nationwide!
https://www.facebook.com/eliot.garza/videos/1744641862216400/
Dr. Doody joins the BOD - Here is the link and article. Yes, he's in the field and I like it:
http://www.otcmarkets.com/stock/ivob/news
INVO Bioscience Appoints Renowned Fertility Specialist Dr. Kevin Doody to its Board of Directors
MEDFORD, Mass., April 11, 2017 /PRNewswire/ -- INVO Bioscience, Inc. (OTC: IVOB), a medical device company who was granted FDA clearance for the first Intravaginal Culture System, INVOcell™, today announced the appointment of Dr. Kevin Doody to its board of directors.
https://mma.prnewswire.com/media/344704/invo_logo_Logo.jpg
Dr. Doody is a renowned fertility specialist who is the founder and Medical Director for the Center for Assisted Reproduction (CARE Fertility) and Effortless IVF located in Bedford, Texas. The Center for Assisted Reproduction, established in 1989, has been a pioneer of assisted reproductive technologies in the north Texas region with several firsts including the first ICSI pregnancy and the first to successfully implement a blastocyst culture system. CARE Fertility had the first pregnancy in the region with a pregnancy following embryo biopsy and pre-implantation genetic testing for cystic fibrosis. CARE Fertility/ Effortless IVF also was the first to adopt the INVOcell™ Intravaginal Culture System since the INVOcell first obtained FDA clearance. Dr. Doody is President of the Society for Assisted Reproductive Technology (SART), on the Board of Directors of the American Society for Reproductive Medicine (ASRM) and a member of the RESOLVE Physician Council.
Dr. Kevin Doody commented, "This is an exciting time for INVO Bioscience. The INVOcell device provides a disruptive alternative to the high expense of construction and maintenance IVF laboratories. Used in concert with new methods to individualize and personalize treatment, the INVOcell will improve access to fertility treatment. Geographic, financial and other barriers to IVF will be reduced. INVOcell provides a more natural solution to infertility with fertilization and early embryo development occurring in the woman's reproductive tract rather than artificial incubators."
Katie Karloff, Chair and Chief Executive Officer of INVO Bioscience, commented, "We are thrilled to have Kevin join INVO Bioscience's board of directors. Kevin is considered one of the foremost thought leaders within the fertility industry and was an early adopter of the INVOcell technology and procedure. We look forward to Kevin's leadership and influence in the coming years as we look to increase access to care and expand fertility treatment across the globe."
About INVO Bioscience
We are a medical device company focused on creating simplified, lower cost treatments for patients diagnosed with infertility. Our solution, the INVO Procedure, is a disruptive new technology. The INVO Procedure is a revolutionary in vivo method of vaginal incubation that offers patients a more natural and intimate experience. Our lead product, the INVOcell, is a patented medical device used in infertility treatment and is considered an Assisted Reproductive Technology (ART). The INVOcell is the first Intravaginal Culture (IVC) system in the world used for the natural in vivo incubation of eggs and sperm during fertilization and early embryo development, as an alternative to traditional In Vitro Fertilization (IVF) and Intrauterine Insemination (IUI). Our mission is to increase access to care and expand fertility treatment across the globe with a goal to lower the cost of care and increase availability of care. For more information, please visit https://invobioscience.com/.
Safe Harbor Statement
This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The Company invokes the protections of the Private Securities Litigation Reform Act of 1995. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategies, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, as well as statements that include words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are forward-looking statements. All forward-looking statements involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. Factors that may cause actual results to differ materially from those in the forward-looking statements include those set forth in our filings at www.sec.gov. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.
Contact:
Kathleen Karloff, CEO INVO Bioscience, Inc. 978-878-9505 ext. 504
kkarloff@invobio.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/invo-bioscience-appoints-renowned-fertility-specialist-dr-kevin-doody-to-its-board-of-directors-300437745.html
SOURCE INVO Bioscience, Inc.
You are right Stockgenius, he did act like a kid most of the time but he stressed that he wanted financials done and they've moved very slow on that. I agree with him for a stop sign on a stock is not a good thing and investors don't like seeing that.
Don't get me wrong here. I like the science and I am invested here but that STOP sign has to go and the financials have to come out or new investors won't put there money up for IVOB. Plain and simple -
GLTU
HCIT
Fantastic news this morning... hopefully a very large partnership. Yahoo has article
In my opinion, no he did not. Sounds like a kid who did not get his way.
"Since those changes Dr. Ranoux has voted against virtually all of the actions taken by the Board of Directors"
Did He? Or did he have the best interest of Claude in mind?
Please do not post off-topic tickers to the board.
Claude had the best interests of IVOB and here is his resignation on an 8K and I don't like it, what say you on this MB?
LINK:
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=11987431
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 5, 2017
INVO BIOSCIENCE, INC.
(Exact name of registrant as specified in its charter)
Nevada
333-147330
20-4036208
(State or other jurisdiction of
(Commission
(I.R.S. Employer
Incorporation)
File Number)
Identification No.)
407R Mystic Avenue, Suite 34C, Medford, MA 02155
(Address of principal executive offices) (Zip Code)
(978) 878-9505
(Registrant’s telephone number, including area code)
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 FR 240.13e-4(c))
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
In the evening of April 5, 2017, Claude Ranoux submitted his letter of resignation effective immediately as a member of the Board of Directors to INVO Bioscience, Inc.’s Board of Director’s Chairperson and CEO Kathleen Karloff. Claude Ranoux stated, “Recent events with respect to the operation of the Board of Directors have limited my ability to effectively serve the company as director.”
Claude Ranoux did not serve on any committee of the Board of Directors at the time of his resignation.
Due to disagreements on how to run the business, Claude Ranoux had initially indicated that he wanted Kathleen Karloff be replaced as an officer. Instead, as previously reported by the Corporation, on September 20, 2016 the Board of Directors replaced Claude Ranoux as President and Treasurer, and removed Claude Ranoux as Chief Scientist, of the Corporation, with Kathleen Karloff then being elected Chairman of the Board, President and CEO, and Robert Bowdring being elected Treasurer and Secretary of the Corporation. Claude Ranoux voted against those changes.
Since those changes Dr. Ranoux has voted against virtually all of the actions taken by the Board of Directors, which actions were approved by Ms. Karloff and Mr. Bowdring. Due to these disagreements, Dr. Ranoux has indicated his desire to replace Ms. Karloff and Mr. Bowdring as directors as well as change the Corporation’s management.
The Board of Directors believes Dr. Ranoux’s resignation was caused by Dr. Ranoux ceasing to be the President, Treasurer and Chief Scientist of the Corporation, the election of Ms. Karloff and Mr. Bowdring to their new officer positions.
Dr. Ranoux’s resignation letter is attached as Exhibit 17
A special telephonic Board of Directors meeting was called at 7:00 PM April 5, 2017, at which the Board of Directors discussed and accepted Claude Ranoux’s resignation as a director. The Board determined that it would review a list of potential candidates to fill the vacancy created on the Board of Directors by Dr. Ranoux’s resignation. A Board of Directors meeting had been previously scheduled for April 7, 2017.
INVO Bioscience would like to thank Claude Ranoux for his efforts over the years.”
Item 9.01
Financial Statements and Exhibits
Exhibit Number
Description
17
Resignation letter dated April 5, 2017.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
INVO Bioscience, Inc. Date: April 7, 2017
By:/s/ Kathleen T Karloff
Kathleen T Karloff
chief Executive Officer and Chairman of the Board of Directors
Exhibit 17
April 5 , 2017
BY EMAIL AND FEDERAL EXPRESS
Board of Directors
INVO Bioscience, Inc.
Attn: Kathleen Karloff
Chairperson and CEO
407R Mystic Avenue
Suite 34C ,
Medford, MA 02155
Dear Ms. Karloff:
This lette r is to indicate my intention to resign from the Board of Directors of INVO Bioscience Inc. , effective immediately.
Recent events with respect to the operation of the Board of Directors have limited my ability to effectively serve the company as a director. I appreciate the opportunity to have served the company and its shareholders since its inception .
Sincerely yours ,
/s/ Claude Ranoux
Claude Ranoux
cc: Robert J. Bowdring
The company is gaining huge traction as the Invocell will become the deface standard for infertility treatment ..
See all of the new clinics now offering the device/procedure.. www.invobioscience.com
ultimately they should be acquired for 5 to 10 current valuation
Like I said Sixth, I am staying here, just wanting some filings and thanks for responding - Hope your weekend was wonderful
HCIT
As someone playing this since 2014, this can't be compared to typical stinky pinkys. Sure it's a pink but it is the exception to the rule that they are all just for trading. Read the filings, research the history. Compare their public conduct and acclaim to other OTC stocks. You'll find a bit of rationale, as opposed to conditioned concern, will reap you many rewards.
Short, I not asking for much here. Yes, they just filed but if you've invested in sub $1 stocks in your life, you'll know what I mean. I am not at INVO's corporate location so I can't see what they are doing but so many sub $1 companies promise the champagne but give you ripple wine, I just want to see the last 2 filings that they are working on to prove to me that this is not just pie in the sky.
I know they have a device and people are being trained with it to demo the real world. I just want to see the "proof in the pudding".
I am here to stay invested so I wish you the best
HCIT
umm, maybe I missed it but isn't that what they are currently doing?
They just filed the 5yr 10-k and will soon be filing the 10-k for 2016 as well as the qtr reports.
What part am I missing?
Hi, yes have been quietly in the background waiting for IVOB to do its thing. I see this one as unique in the penny world cause we actually have a product that is being sold and a company with real value. Of course, the irony of the situation is that these legit ones are usually the ones that take a while to get going.
SixthCents, it's not too much I believe to be compliant with their SEC filings now is it? I agree IVOB is long term and their future is bright but get SEC compliance, that's all. I am not asking for the whole pie, just an SEC piece and stay up to date. It's not as if their accounting at this stage of their company is so complicated with so many checks coming in and going out plus salaries and fees, & fundings +++! GLTU
HCIT
Wow Strat, you havent been on here since like 2015.
Of course you would like to see that, we all would. But really, you're asking for your cake and want to eat it too. If they had all these things, your entry price would be much higher. You will soon reap the rewards of patience and foresight if you just hold patiently.
IVOB - I believe one day we'll all wake up to news that a larger player has bought them out for multiple dollars per share. They're gaining traction and they're getting results. Time will tell.
I do see it as a LT investment but I would like to see them get SEC compliance and some fadder to show us more, that's all - GLTU
HCIT
I don't know, if that were the case we should have seen some of the qtr reports by now. I doubt they would file each qtr report and the annual rpt on Fri but I suppose it is possible.
Ahab, if you only got in 30 days ago, what was your plan for this trade?
-Are you banking on a buyout?
-Are you willing to wait for INVO to achieve their business plan and rollout the product to clinics, ob/gyn offices, etc?
-Imo, this in no-way is a quick trade. It's a long-term investment
Right; they said they expect to file on time, which is Friday.
We wont see the Stop, No Info come down until we get the current quarterlies and annual report for 2016.
Run up might have started today right before close!
Stop sign should come down by Friday. Big plans thereafter.
stockgenius45 Tuesday, 03/14/17 09:21:26 PM
Re: None
Post #
834
From what it sounds like from Katie, she and Dr Doody are al over the place actively training at least 40+ doctors on this technology and PROCEDURE with higher than average success in some of their top clinics and of course over 80% success in Texas. NOTE: It's not just the INVOCell that will make this a homerun. It's the procedure used with the INVOCEll that makes this a huge success.
I asked Katie why haven't we seen these numbers for the 30 clinics. She said that she can't until the financials are released. She's been very frustrated with the fact that others in charge of the financials can't seem to get them done. This is not another Dr. Renaeux scenario, but someone that's taking longer than expected. All that appear to be behind us as she reassured me that by the end of the month the financial through 2015 will be made available and soon thereafter 2016 with all the details of clinics using it and units sold. Although she was eager to get them pubnlished too, I'm still not confident that they may be ready. That is the strange part, but from what I can see by the number of clinics active and hearing about some asking for refills of the INVOCell that this will take off.
I must've mentioned how important it is to get the financials done in our conversation a million times. She knows it. Now they just need to get it done. It appears to be quick a process and with only one person doing it, this is they way it will be.
Of course, once the financial come, financing can be done to hire a new CEO later in the year followed by a Sales and Marketing Director to go to market and really expand in force. They just don't have the money or time to do that now. They're too busy training those using it and are waiting for its success to help move it to the next level.
Cburg, nice find on IVOB being in the top companies in their field. The only thing that bothers me is that no news (outside of filings up to 2015) since November last year and what about 2016 quarterly's and annual filings. They are so far behind that it irks me. Wondering how long I am going to stay invested even though I just got in 30 days or so ago. SP is languishing here .24 - .40 with no volume - GLTU
HCIT
INVO Bioscience listed among top IVF companies:
https://www.whatech.com/market-research/medical/277306-system-integration-services-market-to-grow-at-4-11-cagr-to-2021
New Great Article:
http://frankopolo.com/diy-fertility-is-so-hot-right-now/
I hope so SG, we shall see after & when they come out to update us especially since it's in more clinics now - GLTU
HCIT
No news??? Financials up to 2015 late Friday.... fantastic items in that release (no dilution, per treatment costs, other sources of revenue... etc).
That also means financials last years financials are not too far away (few weeks max) which will show post FDA efforts and most of all get them current which will open up avenue to a bunch of investors!
UP nearly 23% this morning on 75K volume. What's up with this since no news or sec filings - GLTA & Cburg
HCIT
Update from Katie!!!!!
From yahoo board (Brian) - I really hope it is all true
Update from Katie!!!!!
From yahoo board (Brian) - I really hope it is all true
I know it's frustrating, but I had a recent meeting with Katie who provided some information you can find by calling the 30+ clinics now using it that show how the INVOCell is starting to take off like a rocketship. You better lock in your seat belt, load up on shares now and buy on the dips (however they occur) and get ready for takeoff if you believe that this disruptive technology and procedure is going to revolutionize the IVF market by providing IVF at a fraction of the cost when compared to traditional IVF.
A HUGE part of its success is Dr. Doody and Katie who have amazing personalities with doctors recently coming to them by referral and word of mouth to use the INVOCell and its procedure . The clinic in Calgary is planning to open 10 more like it. 100 patients x 10 clinics x $500/Invocell is $500K just from the 10 clinics.. According to this official site, https://www.bls.gov/oes/current/oes291064.htm, there are 20,000 that could administer the INVOCell. So, let's go back to math class again. $500/INVOC Cell x 100 patients per clinic x 20,000 gynecologists = $1,000,000,000. That's $1B company now valued at $20M. That's a 50X multiple to where the stock is right now. If you take into consideration the total shares outstanding (more than just those we know about), maybe we're at 30X multiple. Assume they do half that amount that's a 15X multiple making the stock price around $4. But if they do all of it, that puts the stock at $8 and if there's less stock I suggested even higher.
So with al the hubub, WHY ARE WE AT $0.25. well.... IMO.... All respect to Dr Renauex, but from some clinics I called they told me he was not easy to work with, used an inferior procedure using the INVOCell, and due to poor communication skills left many no longer interested in the INVOCell. When you go to buy a car, if you like the salesperson, you'll likely go for it. It's my impression from those he worked with that he was not a prince charming but more of a negative complainer you don't want to work with. We was fired by Katie. He was one of those people great at being the science behind it, but was horrible at bringing it to market. It is my opinion they it is his fault that this ground breaking disruptive technology has been held back. Even if you have the best idea in the world, you have to bring it to the doctors and prove to them to give up what they're doing. He wasn't good at that . Sorry Dr Renaux, but i don't know you personally and wish you the best of luck but I'm really glad you're out of the picture.
From what it sounds like from Katie, she and Dr Doody are al over the place actively training at least 40+ doctors on this technology and PROCEDURE with higher than average success in some of their top clinics and of course over 80% success in Texas. NOTE: It's not just the INVOCell that will make this a homerun. It's the procedure used with the INVOCEll that makes this a huge success.
I asked Katie why haven't we seen these numbers for the 30 clinics. She said that she can't until the financials are released. She's been very frustrated with the fact that others in charge of the financials can't seem to get them done. This is not another Dr. Renaeux scenario, but someone that's taking longer than expected. All that appear to be behind us as she reassured me that by the end of the month the financial through 2015 will be made available and soon thereafter 2016 with all the details of clinics using it and units sold. Although she was eager to get them pubnlished too, I'm still not confident that they may be ready. That is the strange part, but from what I can see by the number of clinics active and hearing about some asking for refills of the INVOCell that this will take off.
I must've mentioned how important it is to get the financials done in our conversation a million times. She knows it. Now they just need to get it done. It appears to be quick a process and with only one person doing it, this is they way it will be.
Of course, once the financial come, financing can be done to hire a new CEO later in the year followed by a Sales and Marketing Director to go to market and really expand in force. They just don't have the money or time to do that now. They're too busy training those using it and are waiting for its success to help move it to the next level.
Wow! This was a long one. but my point is, I'm a believer. The price will suffer int he immediate term, but IMO by the end of this year we'll be looking back at this and laughing how silly it was for us to worry. The ultimate would be some sort of buyout. She didn't mention any likely buyers. But I'm thinking who would be the best to get the INVOCell out itself? I asked Katie that question but didn't have any answers. Not sure who would buy them, but hopefully someone in the market who could quickly infuse the INVOCell and its procedure into the traditional IVF market quickly to many at once. I was thinking since the procedure still requires some IVF stimulation, then what about an IVF drug company that could do this I wonder? Or Medical Device Companies that would do this?
Update from Katie!!!!!
From yahoo board (Brian) - I really hope it is all true
I know it's frustrating, but I had a recent meeting with Katie who provided some information you can find by calling the 30+ clinics now using it that show how the INVOCell is starting to take off like a rocketship. You better lock in your seat belt, load up on shares now and buy on the dips (however they occur) and get ready for takeoff if you believe that this disruptive technology and procedure is going to revolutionize the IVF market by providing IVF at a fraction of the cost when compared to traditional IVF.
A HUGE part of its success is Dr. Doody and Katie who have amazing personalities with doctors recently coming to them by referral and word of mouth to use the INVOCell and its procedure . The clinic in Calgary is planning to open 10 more like it. 100 patients x 10 clinics x $500/Invocell is $500K just from the 10 clinics.. According to this official site, https://www.bls.gov/oes/current/oes291064.htm, there are 20,000 that could administer the INVOCell. So, let's go back to math class again. $500/INVOC Cell x 100 patients per clinic x 20,000 gynecologists = $1,000,000,000. That's $1B company now valued at $20M. That's a 50X multiple to where the stock is right now. If you take into consideration the total shares outstanding (more than just those we know about), maybe we're at 30X multiple. Assume they do half that amount that's a 15X multiple making the stock price around $4. But if they do all of it, that puts the stock at $8 and if there's less stock I suggested even higher.
So with al the hubub, WHY ARE WE AT $0.25. well.... IMO.... All respect to Dr Renauex, but from some clinics I called they told me he was not easy to work with, used an inferior procedure using the INVOCell, and due to poor communication skills left many no longer interested in the INVOCell. When you go to buy a car, if you like the salesperson, you'll likely go for it. It's my impression from those he worked with that he was not a prince charming but more of a negative complainer you don't want to work with. We was fired by Katie. He was one of those people great at being the science behind it, but was horrible at bringing it to market. It is my opinion they it is his fault that this ground breaking disruptive technology has been held back. Even if you have the best idea in the world, you have to bring it to the doctors and prove to them to give up what they're doing. He wasn't good at that . Sorry Dr Renaux, but i don't know you personally and wish you the best of luck but I'm really glad you're out of the picture.
From what it sounds like from Katie, she and Dr Doody are al over the place actively training at least 40+ doctors on this technology and PROCEDURE with higher than average success in some of their top clinics and of course over 80% success in Texas. NOTE: It's not just the INVOCell that will make this a homerun. It's the procedure used with the INVOCEll that makes this a huge success.
I asked Katie why haven't we seen these numbers for the 30 clinics. She said that she can't until the financials are released. She's been very frustrated with the fact that others in charge of the financials can't seem to get them done. This is not another Dr. Renaeux scenario, but someone that's taking longer than expected. All that appear to be behind us as she reassured me that by the end of the month the financial through 2015 will be made available and soon thereafter 2016 with all the details of clinics using it and units sold. Although she was eager to get them pubnlished too, I'm still not confident that they may be ready. That is the strange part, but from what I can see by the number of clinics active and hearing about some asking for refills of the INVOCell that this will take off.
I must've mentioned how important it is to get the financials done in our conversation a million times. She knows it. Now they just need to get it done. It appears to be quick a process and with only one person doing it, this is they way it will be.
Of course, once the financial come, financing can be done to hire a new CEO later in the year followed by a Sales and Marketing Director to go to market and really expand in force. They just don't have the money or time to do that now. They're too busy training those using it and are waiting for its success to help move it to the next level.
Wow! This was a long one. but my point is, I'm a believer. The price will suffer int he immediate term, but IMO by the end of this year we'll be looking back at this and laughing how silly it was for us to worry. The ultimate would be some sort of buyout. She didn't mention any likely buyers. But I'm thinking who would be the best to get the INVOCell out itself? I asked Katie that question but didn't have any answers. Not sure who would buy them, but hopefully someone in the market who could quickly infuse the INVOCell and its procedure into the traditional IVF market quickly to many at once. I was thinking since the procedure still requires some IVF stimulation, then what about an IVF drug company that could do this I wonder? Or Medical Device Companies that would do this?
Awesome! They need to post this on the website. Then, we need a nationally published interview!
In the news, FOX 2 Now - St Louis...
Expert discusses ‘do-it-yourself’ IVF treatment
http://fox2now.com/2017/03/13/expert-discusses-do-it-yourself-ivf-treatment/
Kinda funny though, your name is what I jokingly quoted as my target, $7.77 only because I saw this as my Vegas jackpot play.
So take that with a grain of salt.
Hollywood, I am not aware of any stock price cap for an OTC stock.
As far as where would I sell, it's too early to say. We don't have enough data as to estimate a stock price. We don't know anything about their franchise deals, partnerships, product pricing, etc.
We are just learning they have almost doubled the number of clinics where the INVOcell product will be available and that is definitely good news but still not enough data. Again, this is not a quick trade for me, your timeframe may be different.
Also, I would err on caution. I'm not one to give ridiculous price targets based on hot air or dubious claims of impending buyouts which several people did leading up to the FDA clearance and after. Regardless you would have to be a fool to believe any of these claims for the same reason we have today, the company is not fully reporting so any of those claims were just speculation.
I'm fairly certain there are bagholders based on those claims but they only have themselves to blame for that. I think at one point I stated that I thought it could get to the $1 or $2 at most (it hit $1.49) range but others were claiming $5 or more. I said then that it was dangerous to make those claims based on nothing more than supposed "buy out claims". I even showed other stocks that had been approved moved about 20% or so and that huge gains were not likely.
I know I'm not giving you what you want but hope this helps in some way.
Update from Rob Bowdring:
"It will be a couple days more. The 10-K is done but a board member asked for more time to review and the audit firm's concurring partner needs to review and comment, so it will not be Monday either. I have always been transparent with you and want to stay that way. I am expecting it will be next week, so a few weeks in place of a couple."
A person's strategy (specificslly their target price) is quite personal. Certainly isn't something a wise investor shares on ihub.
Why is that because shorthound is one of the very few that has any sense of what is going on with this stock. He is one of the few that has anything good to say other than where is the financials? I'm sorry but I don't have to have balls to respect his decision. I actually asked these questions because I respect his decisions.
Followers
|
37
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1113
|
Created
|
04/05/09
|
Type
|
Free
|
Moderators |
INVO Bioscience Product InformationINVO Bioscience's INVOcell will revolutionize the treatment of infertility. The INVOcell, pictured below, replaces the IVF laboratory and allows conception to take place naturally inside the woman's body. INVO Bioscience's INVOcell device and the INVO process will be much less expensive than traditional IVF and is comparable in pregnancy rate. Also, the INVO procedure is simple so it will be available in physician's offices. The INVOcell Device The INVOcell device and procedure were developed by Dr. Claude Ranoux. Over 800 clinical cases using prototype devices have been published in the medical literature. The INVOcell is a precisely designed and manufactured device. The INVOcell is manufactured in the U.S. by a company that is ISO-13485 certified. INVO Bioscience has 5 current patents on the INVOcell device and procedure.“This technology represents an exciting and important new treatment option for infertility.” Dr. Leo Bonaventura, INVOcell Clinical Investigator and member of INVO Bioscience's Board of Advisors, |
Chat forum for woman who were in the Trials! Lots of great feedback! |
11/03/2015 - Pr Newswire | |
The Economist-Oct 25, 2014 IT IS not quite do-it-yourself IVF, but it is close. An INVOcell, brainchild of Claude Ranoux of INVO Bioscience, in Medford, Massachusetts, is a device that allows ... | |
The 'champagne cork' mini incubator that could halve cost of IVFDaily Mail-Oct 22, 2014 In a pilot study, women treated using the INVOcell device were just as likely to ... INVO Bioscience hopes to have the device on sale in the US by the end of this ... | |
Mini 'body incubator' may halve cost of IVFIndependent Online-Nov 4, 2014 In a pilot study of 33 infertile women, those treated using the INVOcell ... INVO Bioscience hopes to have the device on sale in the US by the end of this year. | |
The INVO procedure has been published in The Scientific World Journal! INVO Procedure: Minimally Invasive IVF as an Alternative Treatment Option for Infertile Couples Click Here for Active Stock Bid Information IR@INVOBio.com |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |